Messages in brief

News

Comirnaty (COVID-19-mRNA-Vaccine)

messages in brief | 02/06/2021
On May 28, 2021, the use "for active immunization of individuals 12 years of age and older" was extended by the EMA.
Comirnaty (COVID-19-mRNA-Vaccine) Read more
News

Innovation in the eService Marketing Authorisation and Lifecycle

messages in brief | 25/05/2021
As of 22.5.2021, the function "Withdrawal according to §23 AMG" will be available in the area "Overview Medicinal Products".
Innovation in the eService Marketing Authorisation and Lifecycle Read more
News

EU Recommendations for the Seasonal Influenza Vaccine Composition for the Season 2021/2022

messages in brief | 10/05/2021
The EMA adopted the new recommendations for the composition of seasonal influenza vaccines for the season 2021/2022 (published 30 March 2021)
EU Recommendations for the Seasonal Influenza Vaccine Composition for the Season 2021/2022 Read more
News

Current issue of “RMS NEWS”

messages in brief | 30/04/2021
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
Current issue of “RMS NEWS” Read more
News

New recommendation for dosing interval of mRNA-COVID-19 vaccines

messages in brief | 26/03/2021
National Vaccination Committee recommends extended dosage intervals for mRNA vaccines
New recommendation for dosing interval of mRNA-COVID-19 vaccines Read more
News

Release of the temporarily put on hold vaccine batch

messages in brief | 19/03/2021
The Austrian Federal Office for Safety in Health Care (BASG) informs that the temporarily put on hold batch ABV 5300 of AstraZeneca's COVID 19 vaccine has been released again and can be vaccinated.
Release of the temporarily put on hold vaccine batch Read more
News

Incidents after vaccination with AstraZeneca's COVID-19 vaccine

messages in brief | 07/03/2021
Currently, there is no evidence of a causal relationship with vaccination.
Incidents after vaccination with AstraZeneca's COVID-19 vaccine Read more
News

Guidance notes to the processing of DHPC (Direct Healthcare Professional Communication) und Educational Material

messages in brief | 25/02/2021
In cooperation with the pharmaceutical industry, the BASG has produced a guideline for processing DHPC (Direct Healthcare Professional Communication) and Educational Material.
Guidance notes to the processing of DHPC (Direct Healthcare Professional Communication) und Educational Material Read more
News

Authorisation of a third vaccine against COVID-19 (AstraZeneca)

messages in brief | 03/02/2021
On 29. January 2021, "COVID-19 Vaccine AstraZeneca" was authorised in the European Union as the third vaccine against SARS-CoV2.
Authorisation of a third vaccine against COVID-19 (AstraZeneca) Read more
News

Patient-friendly reporting form for adverse reactions

messages in brief | 02/02/2021
To simplify the reporting of suspected adverse reactions of medicines and vaccines a revised online form is now available for patients.
Patient-friendly reporting form for adverse reactions Read more
Email

Further inquiry note